Healio
SearchLoading
Healio
SearchLoading

Mark Genovese, MD

Genovese is the senior vice president of immunology and clinical development at Lilly.
Choose a Section

Most recent by Mark Genovese, MD

SPONSORED CONTENT
June 04, 2024
5 min watch
Save

VIDEO: ‘Compelling data’ from VIVID-1 study support use of mirikizumab in Crohn’s disease

WASHINGTON — In this video, Mark Genovese, MD, discusses results of the VIVID-1 study, in which mirikizumab demonstrated noninferiority to ustekinumab for week 52 clinical remission among patients with moderate to severe Crohn’s disease.